Molecular Templates Competitors and Similar CompaniesClear all

Molecular Templates's competitors and similar companies include Cancer Genetics, Alpha Cancer Technologies, Cancer Prevention Pharmaceuticals and Aravive.

	Molecular Templates Molecular Templates (MTEM) is a biopharmaceutical company focused on the discovery and development of differentiated, targeted, biologic therapeutics for cancer.	Cancer Genetics Cancer Genetics, Inc. (CGI) provides DNA-based cancer diagnostics and services to medical institutions.	Alpha Cancer Technologies Alpha Cancer Technologies is a clinical-stage biotechnology company providing platform technologies in immunotherapy and immuno-oncology.	Cancer Prevention Pharmaceuticals Cancer Prevention Pharmaceuticals is a company developing therapeutics designed to reduce the risk of cancer and other diseases.	Aravive Aravive is a clinical-stage biotechnology company developing therapies for solid tumors and hematologic malignancies.
Founding Date	Founding Date 2009	Founding Date 1999	Founding Date 2008	Founding Date 2008	Founding Date 2008
Type	Type Public	Type Public	Type Private	Type Private	Type Public
Tags	Tags Healthcare biotech clinical research drug development	Tags Healthcare genetics medical diagnostics oncology	Tags Healthcare biotech oncology platform	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech pharma therapy
Locations	Locations Austin, US HQ New York, US	Locations Cherry Hill, US HQ Shanghai, CN Morrisville, US	Locations Toronto, CA HQ	Locations HQ	Locations Houston, US HQ
Employees	Employees 6272% decrease	Employees 15031% decrease	Employees 5	Employees 5	Employees 23
Valuation ($)	Valuation ($) 3.3 m	Valuation ($) 48.7 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 2.9 m
Financial
Revenue (est.)	Revenue (est.) $57.3m (FY, 2023)	Revenue (est.) $666k (FY, 2022)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $9.1m (FY, 2022)
Net income	Net income ($8.1m) (FY, 2023)	Net income ($22.7m) (FY, 2022)	Net income N/A	Net income N/A	Net income ($76.3m) (FY, 2022)
Funding
Total funding raised	Total funding raised $ 89.6m	Total funding raised $ 6.6m	Total funding raised N/A	Total funding raised $ 9.3m	Total funding raised N/A